Larry Todd Edwards - Nov 6, 2025 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Reporting Person's title: EVP Chief Commercial Officer
Signature
/s/ Latha Vairavan, as Attorney-in-Fact for Larry Todd Edwards
Stock symbol
ARQT
Transactions as of
Nov 6, 2025
Transactions value $
-$732,927
Form type
4
Date filed
11/10/2025, 05:42 PM
Previous filing
Oct 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Edwards Larry Todd Reporting Person's title: EVP Chief Commercial Officer C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE /s/ Latha Vairavan, as Attorney-in-Fact for Larry Todd Edwards 2025-11-10 0001994805

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale -$733K -29.1K -16.24% $25.16 150K Nov 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.2600, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Reporting Person's title: EVP Chief Commercial Officer